Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Climate crisis is 'outrunning us', UN chief warns COP31
US House blocks bid to impeach Defence Secretary Hegseth
Threats sent to UK and Irish schools dismissed as hoax
Former Pakistan PM Imran Khan back in jail after medical treatment, sources say
